The largest nationwide SARS-CoV-2 seroprevalence survey, funded by the CDC and supported by 17 blood collection organizations representing blood donations from across all 50 states, Washington D.C., and Puerto Rico, published its latest findings in the Journal of the American Medical Association (JAMA). More than 1.5 million samples from blood donations were tested over 11 months, estimating an 83.3% rate for combined infection- and vaccine-induced antibodies, among other observations.
Vitalant is launching the Vitalant Innovation Center in Denver, Colorado, a key part of the Vitalant Research Institute. Vitalant is investing in the Innovation Center as part of its commitment to advancing the science of transfusion medicine. The center will provide scientific research and translational development expertise to design innovative processes for Vitalant and bring new products to the patients it serves.
Blood collection organizations, testing laboratories and affiliated research institutes continue to play a critical role in the response to the COVID-19 pandemic, and blood centers across the country are proud to be at the forefront.
Antibodies are one of the ways the human body fights infection from the coronavirus. Researchers believe testing for covid-19 antibodies can lead to possible treatments for the virus and help indicate when to reopen society.
People who have recovered from COVID-19 may have an outlet to help those ill with the disease caused by the new coronavirus: Donating their plasma.
In Arizona, a blood donation company, Vitalant (formerly United Blood Services), is starting to allow recovered patients to donate as part of a pilot program.
Blood tests for antibodies to the novel coronavirus will be “foundational, fundamental,” to sending Californians back to work, California Gov. Gavin Newsom said on Monday. But medical experts caution that there’s still a lot we don’t know about whether the tests are reliable enough to ensure people’s safety.